Weight loss should not be pursued during pregnancy regardless of pre-pregnancy weight status
However, for many, the practicalities of weekly injectionsrefrigeration, needle disposal, and the discomfort of administrationpresent obstacles to consistent use
Just look at the hand-wringing in another recent paper that showed high rates of people quitting GLP-1s: "Discontinuation could have policy and medication coverage implications, especially if the weight reduction is not sustained after medications are discontinued," the authors wrote
Understanding tirzepatide dose-response for informed conversion decisions Knowing the conversion math is only half the picture
What to Know About the BALANCE Model for GLP-1s in Medicare and Medicaid and the Medicare GLP-1 Bridge Editorial Note This brief was updated on May 11, 2026 to reflect changes in the Trump administrations plans for implementation of the BALANCE Model in Medicare and an extension of the Medicare GLP-1 Bridge program through 2027
Self-Paced More information coming soon